MedPath
TGA Approval

BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vial (313680)

313680

BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vial

Novartis Pharmaceuticals Australia Pty Ltd

January 16, 2020

Medicine

Medicine

Active

Registered

Product Information

Product Information

https://medical-cdn.nocode.com/drug_tga/3d979f1621ac96e1327b2387969928db.pdf

Active Ingredients

brolucizumab

© Copyright 2025. All Rights Reserved by MedPath
BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vial (313680) - TGA 批准文号 | MedPath